IP Verse

Cooley competitive analysis

Explore patent oppositions filed by Cooley against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP3604532	Novel Crispr Enzymes And Systems	MASSACHUSETTS INSTITUTE OF TECHNOLOGY	Feb 3, 2025
EP4023755	Artificial Nucleic Acid Molecules For Improved Protein Expression	CUREVAC	Jan 26, 2024
EP3882357	Methods And Compositions For Nucleic Acid Analysis	X GENOMICS	May 9, 2023
EP3708668	Artificial Nucleic Acid Molecules For Improved Protein Expression	CUREVAC	Apr 27, 2023
EP2668294	Paired End Bead Amplification And High Throughput Sequencing	THE BROAD INSTITUTE	Jan 7, 2022
EP3511423	Methods And Product For Optimising Localised Or Spatial Detection Of Gene Expression In A Tissue Sample	SPATIAL TRANSCRIPTOMICS	Dec 23, 2021
EP2928496	Crispr-Based Genome Modification And Regulation	SIGMA ALDRICH	Jul 8, 2020
EP3138911	Crispr-Based Genome Modification And Regulation	SIGMA ALDRICH	Sep 5, 2019
EP2937328	Alcohol Production Method	TORAY INDUSTRIES	May 1, 2019
EP2230319	Gene Expression Markers For Breast Cancer Prognosis	GENOMIC HEALTH	Jul 21, 2016

Discover the latest PTAB cases involving Cooley, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Cooley with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
COOLEY UK	10	-	-	-
CUREVAC	1	80	-	1
SIGMA ALDRICH	-	66	-	-
THE BROAD INSTITUTE	-	129	-	1